Human immunodeficiency virus infection and the liver

doi:10.4254/wjh.v4.i3.91

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10193)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

914

HTML

8814

Figures (1-2)

258

Tables (1-1)

207

Sum=10193

Mar 27, 2012 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (44)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Hepatol. Mar 27, 2012; 4(3): 91-98
Published online Mar 27, 2012. doi: 10.4254/wjh.v4.i3.91

Full Size Figure Download Figure

Figure 2 Proposed use of transient elastography (FibroScan) in human immunodeficiency virus infected individuals with raised liver enzymes (adapted from Ref. [91]). HIV: Human immunodeficiency virus; ALT: Alanine aminotransferase; HAV: Hepatitis A virus; HBV: Hepatitis B virus; HCV: Hepatitis C virus; HDV: Hepatitis delta; ART: Anti-retroviral therapy; ddI: Didanosine; d4T: Stavudine; TB: Tuberculosis; HCC: Hepatocellular carcinoma.

Citation: Crane M, Iser D, Lewin SR. Human immunodeficiency virus infection and the liver. World J Hepatol 2012; 4(3): 91-98
URL: https://www.wjgnet.com/1948-5182/full/v4/i3/91.htm
DOI: https://dx.doi.org/10.4254/wjh.v4.i3.91